Life Science REIT (LON:LABS) Posts Quarterly Earnings Results

Key Points

• Life Science REIT (LON:LABS) reported quarterly earnings of GBX 8.50 per share, reflecting a negative net margin of 198.99% and negative return on equity of 14.53%.
• The company has a market capitalization of £136.50 million and a price-to-earnings ratio of -975.00.
• LABS stock opened at GBX 39, with a 1-year trading range between GBX 32 and GBX 49.

Life Science REIT (LON:LABS - ) issued its quarterly earnings results on Tuesday. The company reported GBX (8.50) earnings per share for the quarter, Digital Look Earnings reports. Life Science REIT had a negative net margin of 198.99% and a negative return on equity of 14.53%.

Life Science REIT Trading Up 0.3%

Shares of LABS stock opened at GBX 39 on Tuesday. The stock has a market cap of £136.50 million, a price-to-earnings ratio of -975.00 and a beta of 0.08. The stock has a 50-day moving average of GBX 39.53 and a 200-day moving average of GBX 41.98. Life Science REIT has a 1-year low of GBX 32 and a 1-year high of GBX 49.

About Life Science REIT

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.